Literature DB >> 7948305

Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript.

Y Kunieda1, M Okabe, M Kurosawa, T Itaya, M Kakinuma, T Miyazaki.   

Abstract

We investigated the breakpoints of the bcr gene in 46 Ph1-positive CML cases by Southern blot analysis of bcr rearrangement, and in 17 CML cases by a combination of Southern blot analysis and RT-PCR. By Southern blot, the breakpoint was not identified on M-bcr in three CML cases, of which one case showed the P210-type bcr/abl transcript and two cases showed the ALL-type (P190-type) bcr/abl transcript with or without P210 transcript. Later two cases showed unique hematological profiles such as thrombocytosis, mild myelofibrosis, and relative resistance to alkylating agents. Therefore, the present study suggests that expression of the P190-type transcript may affect clinical and hematological findings in CML.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948305     DOI: 10.1007/bf02215952

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  28 in total

Review 1.  Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects.

Authors:  R Berger; S J Chen; Z Chen
Journal:  Cancer Genet Cytogenet       Date:  1990-02

2.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

3.  Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction.

Authors:  M S Lee; A LeMaistre; H M Kantarjian; M Talpaz; E J Freireich; J M Trujillo; S A Stass
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

4.  Frequent and extensive deletion during the 9,22 translocation in CML.

Authors:  D W Popenoe; K Schaefer-Rego; J G Mears; A Bank; D Leibowitz
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

5.  A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia.

Authors:  L C Chan; K K Karhi; S I Rayter; N Heisterkamp; S Eridani; R Powles; S D Lawler; J Groffen; J G Foulkes; M F Greaves; L M Wiedemann
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

6.  Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia.

Authors:  M Okabe; S Matsushima; M Morioka; M Kobayashi; S Abe; K Sakurada; M Kakinuma; T Miyazaki
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

7.  Molecular cloning of a 5' segment of the genomic phl gene defines a new breakpoint cluster region (bcr2) in Philadelphia-positive acute leukemias.

Authors:  S J Chen; Z Chen; J D Grausz; J Hillion; L d'Auriol; G Flandrin; C J Larsen; R Berger
Journal:  Leukemia       Date:  1988-10       Impact factor: 11.528

8.  Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products.

Authors:  J B Konopka; O N Witte
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

9.  Philadelphia-positive chronic myelogenous leukemia with breakpoint 5' of the breakpoint cluster region but within the bcr gene.

Authors:  C R Bartram; U Bross-Bach; H Schmidt; H D Waller
Journal:  Blut       Date:  1987-12

10.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

View more
  1 in total

1.  Reversal effect of itraconazole on adriamycin and etoposide resistance in human leukemia cells.

Authors:  M Kurosawa; M Okabe; N Hara; K Kawamura; S Suzuki; K Sakurada; M Asaka
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.